Lion's Mane and Chaga: Benefits, Forms, Dosing, and Side Effects

Lion's mane (Hericium erinaceus) and chaga (Inonotus obliquus) are two fungi with long histories of use in traditional medicine, particularly in East Asia and Northern Europe. Both are widely marketed as dietary supplements with claims ranging from cognitive enhancement to immune support. However, the clinical evidence behind these two organisms differs substantially — and in many cases falls short of the marketing claims. This comprehensive guide examines every available human study, details the forms and quality issues consumers should know about, and provides evidence-based safety information.

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Lion's Mane

Lion's mane is an edible mushroom that grows on living or dead broadleaf trees, primarily hardwoods such as oak, beech, maple, and walnut [1][2]. It is consumed as a food in Japan and China, where it is known as yamabushitake (mountain monk mushroom) and hóutóugū (monkey head mushroom), respectively [2]. The mushroom's distinctive white, cascading, spine-covered fruiting body — resembling a lion's mane — typically measures 8–24 cm in diameter and is found in temperate forests across North America, Europe, and Asia [2][3].

Like other fungi, lion's mane consists of two main parts: the fruiting body (the visible "mushroom" growing above the surface) and the mycelium (the underground root-like network). This distinction is critical for supplement consumers because the bioactive compounds differ between these parts [1][4].

Test-tube studies have shown that chemicals in lion's mane called hericenones (found primarily in the fruiting body) and erinacines (found primarily in the mycelium) can promote the production of nerve growth factor (NGF) in cells of the nervous system [4][5]. NGF is a protein essential for the growth, maintenance, and survival of neurons — particularly cholinergic neurons that tend to decline in activity with age and in Alzheimer's disease [4][6][7]. Japanese researcher Hirokazu Kawagishi and colleagues first identified these NGF-stimulating compounds in the 1990s, isolating erinacines A, B, and C in 1994 and demonstrating their potent stimulatory effects on NGF production in cell cultures [8][9]. Subsequent isolations of erinacines E, F, and G in 1996 further confirmed their NGF-promoting activity [10].

Lion's mane also contains beta-glucans (mainly in the fruiting body) and alpha-glucans (mainly in the mycelium), which are naturally occurring polysaccharides that have been shown in laboratory and animal studies to have anti-cancer, antioxidant, anti-inflammatory, and immunomodulatory effects [1][11]. However, laboratory research with human blood cells found that mycelium extract reduced certain markers of inflammation, while fruiting body extract actually increased a key marker of inflammation, suggesting the two parts may have opposing immune effects [12]. The beta-glucans in lion's mane are chemically distinct from the beta-glucan found in oats and other cereals, which has a well-established cholesterol-lowering effect [11][13].

Commercially available lion's mane supplements in the U.S. are generally not standardized to erinacine or hericenone content, and there are currently no certified reference standards or compendial analytical methods available for these compounds [1].

Chaga

Chaga (Inonotus obliquus) is not technically a mushroom but rather a fungal growth (sclerotium) consisting of mycelium that forms most commonly on birch trees in response to infection, typically in colder climates such as Northern Europe, Siberia, Russia, Korea, and Northern Canada [1][14]. Due to its tough, charcoal-like exterior texture, chaga has traditionally been consumed as a tea or extract rather than eaten directly [14].

Chaga supplements are typically made from the mycelium, which contains predominantly alpha-glucans and little to no beta-glucans [15]. When a birch tree dies, chaga may produce a fruiting body (sporocarp) under the bark, which does contain beta-glucans. Some supplements use this fruiting body material [1].

Laboratory and animal studies suggest chaga may have potential benefits for immune function, blood sugar regulation, and anti-tumor activity. However, there do not appear to be any published clinical trials that have investigated the effects of chaga tea or supplements in people [1]. This is a critical distinction: all evidence for chaga's health effects comes from cell studies and animal models.

Nutritional Profile of Lion's Mane

Per 100 grams of fresh lion's mane fruiting body [2][16]:

Nutrient	Amount	% Daily Value
Calories	43 kcal	—
Protein	2.5 g	—
Carbohydrates	7.6 g	—
Dietary Fiber	4.4 g	—
Beta-glucans	~2.4 g	—
Fat	0.3 g	—
Biotin	17 mcg	57%
Riboflavin (B2)	0.36 mg	28%
Thiamin (B1)	0.15 mg	13%
Niacin (B3)	1.63 mg	10%
Potassium	443 mg	9%
Folate	30 mcg	8%
Zinc	0.74 mg	7%
Phosphorus	94 mg	—
Iron	0.69 mg	4%
Vitamin B6	0.07 mg	4%
Magnesium	11.7 mg	3%

Adding lion's mane to coffee has become a trend marketed as a healthier alternative to regular coffee. However, a study found that a small amount (2 grams) of lion's mane fruiting body powder added to instant coffee provided no meaningful increases in meeting the Daily Value for essential minerals. The greatest increase was for iron, going from 2% DV with instant coffee alone to just 3% DV with lion's mane added [17].

Forms and Bioavailability

Lion's Mane Forms

Lion's mane supplements vary widely in their chemical composition depending on which part of the fungus is used and how it is processed. Understanding these differences is essential for evaluating product quality.

Fruiting body products are derived from the visible mushroom portion. They tend to contain higher concentrations of beta-glucans (the primary polysaccharides thought to contribute to immune and antioxidant effects), hericenones (diterpenoid compounds shown to stimulate NGF synthesis in cell cultures), and higher concentrations of minerals, B vitamins, and dietary fiber [1][4][5][15][16].

Mycelium products are derived from the root-like network. They tend to contain erinacines (cyathane diterpenoid compounds shown to stimulate NGF synthesis, distinct from hericenones), alpha-glucans rather than beta-glucans, and potentially residual grain substrate since mycelium is typically grown on grain [1][4][5][8][15][18].

Extract products should contain higher concentrations of bioactive compounds than products that are simply dried, powdered mushroom. However, the specific extraction method (hot water, ethanol, dual extraction) affects which compounds are present. Hericenones are more soluble in ethanol, while beta-glucans are more water-soluble [1][2].

Critical Quality Issues

Mycelium-on-grain products: Many mycelium supplements sold in the U.S. are grown on grain substrates (rice, oats, sorghum), and the final product may contain substantial amounts of grain rather than pure mycelium. Labels may list "mushroom" but indicate the ingredient is from mycelium — these products do not technically include mushroom (the fruiting body) [1].

Chaga myceliated grain concerns: An analysis of four commercially available chaga "mycelium fermented grain" supplements found they contained similar amounts of alpha-glucans and beta-glucans as the grain substrates alone (47–74% alpha-glucan and 1–7% beta-glucan in powdered brown rice, oats, and sorghum). Furthermore, these supplements did not contain constituents found in whole chaga, such as melanin, triterpenoids, and ergosterol, but did contain relatively high amounts of linoleic and oleic acids found only in the grains [18]. This suggests some myceliated grain products may be more grain than fungus.

Unlike many herbal supplements, lion's mane products are generally not standardized to specific bioactive compound content (hericenones, erinacines). The beta-glucan content listed on some labels is a more reliable quality indicator — fruiting body extracts typically contain higher beta-glucan levels than mycelium products [1][15].

Chaga Forms

Chaga supplements are available as whole dried chunks (traditionally brewed as tea), powdered chaga (ground mycelium or sclerotium), extracts (concentrated preparations using hot water, ethanol, or dual extraction), and myceliated grain products (mycelium grown on grain substrate, with quality concerns noted above).

The key distinction for chaga is between the external sclerotium (the charcoal-like growth on living trees, primarily mycelium and tree components) and the rare fruiting body (which forms under the bark of dying trees). The sclerotium contains primarily alpha-glucans, while the fruiting body contains beta-glucans [1][15]. Chaga supplements may also contain components of wood from the affected tree [19].

Form Comparison Table

Feature	Fruiting Body Products	Mycelium Products	Myceliated Grain Products
Beta-glucan content	High	Low	Very low (similar to grain alone)
Alpha-glucan content	Low-Moderate	High	High (may be from grain)
Hericenones (lion's mane)	Present	Absent or low	Absent or low
Erinacines (lion's mane)	Absent or low	Present	Variable
Grain filler content	None	None to low	Potentially high
Melanin/triterpenoids (chaga)	Variable	Variable	Absent

Evidence for Benefits

Lion's Mane: Cognitive Function and Memory

Lion's mane is most commonly promoted for improving cognitive function, but the clinical evidence is limited and conflicting. The research suggests that lion's mane might help people with mild cognitive impairment, but it does not appear to benefit people with Alzheimer's disease or healthy adults.

Healthy Adults — No Convincing Benefit

Multiple studies in healthy adults have failed to show cognitive benefits from lion's mane supplementation:

Study 1 — Healthy older adults (Japan): A study of 31 healthy older adults (average age 61) given supplements providing 3.2 grams of powdered lion's mane fruiting body or placebo daily for 12 weeks found that, compared to placebo, those given lion's mane showed only very slight improvement in overall score on the Mini Mental State Examination (MMSE). However, there was no difference between groups on subscales measuring memory, orientation, or math skills, and there was no improvement on two other cognitive tests [20].

Study 2 — Healthy young adults (U.S.): A study of 24 healthy young adults (average age 22) showed that taking 5 grams of lion's mane (1:1 dried mushroom:extract, standardized to 33.69% beta-glucans, from Nammex Organic Mushroom Extracts) twice daily for 4 weeks did not improve cognitive performance during a dual-task challenge (cognitive test during physical balance test), nor did it improve metabolic flexibility compared to placebo [21].

Study 3 — Healthy young adults (manufacturer-funded): A manufacturer-funded study of 40 healthy young adults (average age 34) showed that taking 1 gram of 100% Nordic lion's mane fruiting bodies two hours before cognitive testing did not improve reaction time, mental clarity, focus, concentration, working memory, or accuracy compared to placebo [22].

Study 4 — Healthy young adults (U.K.): A study of healthy young adults showed that taking 3 grams of lion's mane fruiting body extract 90 minutes before cognitive testing did not improve executive function, visual attention, motor speed, reaction time, overall cognitive performance, or mood compared to placebo. The supplement actually showed slight worsening in a test evaluating selective attention and impulse control [23].

Study 5 — Healthy young adults (pilot study): A double-blind, placebo-controlled RCT of 41 healthy young adults investigated acute and chronic supplementation with 1.8 g/day of lion's mane for 28 days. Acute administration improved speed on the Stroop task (p=0.005), and chronic supplementation showed a trend toward reduced subjective stress (p=0.051), but chronic effects were inconsistent, with no significant overall improvements in global cognition or mood [24][25].

Mild Cognitive Impairment — Positive but Limited

Study 6 — Mild cognitive impairment (Japan): The most frequently cited positive study included 29 Japanese adults (age range 50–80) with mild cognitive impairment who were given tablets providing 960 mg of air-dried, powdered lion's mane fruiting body or placebo three times daily (total 2,880 mg/day). After 16 weeks, significantly more people given lion's mane showed "notable" improvement in cognitive function compared to placebo (71% vs 7%). Notable improvement was defined as an increase of at least 3 points on a 30-point cognitive function scale developed by the investigators. However, improvements tended to decline within 4 weeks of stopping treatment [26].

A 2024 systematic review that synthesized evidence from multiple studies on mushrooms' effects on mood and neurocognitive health found that lion's mane supplementation showed some enhancement of mood and cognitive function in middle-aged and older adults, but results were mixed, and most studies involved small sample sizes (under 50 participants) [27][28].

Alzheimer's Disease — No Significant Benefit

Study 7 — Mild Alzheimer's disease (China): A study of 41 older adults (average age 76) with mild Alzheimer's disease were given 1.05 grams of lion's mane mycelium extract enriched with erinacine A (5 mg erinacine A per gram of extract) or placebo three times daily with meals (total 3.15 g/day). After 49 weeks, people given lion's mane did not show significantly greater improvement in most measures of cognitive function compared to placebo. The lion's mane group showed only slightly greater improvement on the Instrumental Activities of Daily Living scale, which relates to ability to live independently [29].

Summary of Cognitive Evidence

Population	Studies	Typical Dose	Duration	Result
Healthy young adults	4 studies	1–10 g/day	Acute to 4 weeks	No convincing benefit
Healthy older adults	1 study	3.2 g/day	12 weeks	Minimal benefit
Mild cognitive impairment	1 study	2.88 g/day	16 weeks	Positive (71% vs 7% improved)
Mild Alzheimer's disease	1 study	3.15 g/day (erinacine-enriched)	49 weeks	No significant benefit

Lion's Mane: Depression and Anxiety

Lower levels of nerve growth factor have been linked with major depressive disorder [30]. Based on lion's mane's ability to stimulate NGF production, there is interest in using it for depression, but no strong clinical evidence supports this use.

Study 1 — Healthy women (Japan): A study of 26 healthy women (average age 40) who ate four cookies each containing 500 mg of lion's mane powdered fruiting body (total daily dose 2,000 mg) for 4 weeks showed slightly reduced depression scores. However, this improvement was not statistically significant compared to the placebo group, which also showed a reduction in depression scores [31].

Study 2 — Overweight/obese women with mood disorders: A study of 72 women who were overweight or obese and had at least one mood disorder (depression, anxiety, or binge-eating) showed that following a low-calorie diet and supplementing with three capsules of lion's mane (providing 1,200 mg of mycelium and 300 mg of fruiting body extract daily) for 8 weeks did not reduce depression symptoms overall compared to baseline or compared to the control group. However, those supplementing with lion's mane showed a 12.6% decrease in anxiety compared to baseline, while the control group showed no improvement. It was not shown whether this anxiety improvement was statistically significant [32].

Study 3 — Menopausal women (Japan): In menopausal women consuming 2 g/day via cookies for 4 weeks, significant decreases in depression and anxiety scores were observed on the Kupperman Menopausal Index and Indefinite Complaints Index [31][33].

Study 4 — Overweight adults (8-week trial): In overweight and obese adults, 550 mg/day supplementation for 8 weeks, combined with a low-calorie diet, led to lowered depression, anxiety, and sleep disorder scores, potentially linked to increased pro-brain-derived neurotrophic factor (BDNF) levels [34].

The evidence for lion's mane treating depression or anxiety is preliminary. Small studies show mixed results, with most improvements either not reaching statistical significance or confounded by concurrent dietary interventions. Larger, well-designed RCTs are needed.

Lion's Mane: Gut Health

Lion's mane has drawn interest for gut health based on preclinical evidence. A test-tube study showed that lion's mane could inhibit the activity of H. pylori, a bacteria that commonly causes stomach ulcers [35]. A study in mice showed that lion's mane protected against alcohol-induced stomach ulcers [36].

However, there do not appear to be any studies investigating the effects of lion's mane alone on gut health in humans. Studies evaluating supplements containing lion's mane combined with other mushrooms have shown conflicting results.

Ulcerative colitis (positive): A study of people with ulcerative colitis showed that taking 60 mL of a mushroom extract (AndoSan by Immunopharma AS) containing approximately 15% lion's mane along with 82% Agaricus blazei Murill and approximately 3% maitake mushroom daily for 3 weeks improved symptoms compared to placebo [37].

Crohn's disease (negative): Taking the same dose of the same supplement for the same duration showed no benefit for people with Crohn's disease [37]. It remains unclear whether any observed gut health effects are due to lion's mane, other mushroom constituents, or the combination.

Lion's Mane: Nerve Injury and Neuropathy

In animal studies, lion's mane extract has been shown to speed recovery of peripheral nerve injury faster than vitamin B12 (which has some evidence for peripheral neuropathy in humans) [38], reduce nerve pain caused by the chemotherapy drug cisplatin [39], and reduce sensitivity to pain in chemically induced diabetic neuropathy (polysaccharides isolated from fruiting bodies) [40].

In vitro studies have demonstrated that extracts enriched with hericenones and erinacines promote neurite outgrowth in neuronal cell lines (PC12 cells and neuroblastoma cells) by enhancing NGF signaling pathways [6][7]. Research also indicates that erinacine S may protect oligodendrocytes and promote myelin sheath formation, as shown by increased myelin basic protein expression in cell cultures and animal models of demyelination [41].

However, there does not appear to be any research investigating the effects of lion's mane on neuropathy conditions in people [1]. The animal data is promising but requires human confirmation.

Lion's Mane: Sleep

Preliminary research suggests indirect sleep support via anxiety and mood improvement rather than a direct sleep effect. Studies have linked lion's mane supplementation to reduced anxiety and insomnia symptoms, potentially by stimulating NGF and balancing mood [2][34]. Animal research indicates positive influences on circadian rhythms. However, direct sleep effects have not been confirmed in controlled human trials, and the evidence remains speculative.

Lion's Mane: Immune and Anti-Cancer Effects

Laboratory and animal studies suggest lion's mane polysaccharides (particularly beta-glucans from the fruiting body) have antioxidant, anti-inflammatory, and immunomodulatory effects [1][11]. However, an important caveat emerged from human blood cell research: mycelium extract reduced certain markers of inflammation, while fruiting body extract increased a key marker of inflammation [12]. This suggests the immune effects may differ — or even be opposing — depending on which part of the fungus is used.

No human clinical trials have specifically evaluated lion's mane for cancer prevention or treatment.

Chaga: Immune Function

Chaga extract from the mycelial portion has been shown in laboratory cell studies and research in mice to promote the production of white blood cells and beneficial cytokines (proteins involved in immune response), indicating an immune-enhancing effect that could potentially help during chemotherapy for cancer [42].

In contrast, an extract of chaga fruiting body (which grows under the bark of dying trees) showed an immune-suppressing effect that could potentially be useful in treating inflammatory bowel disease [43]. This opposing immunological activity between the mycelium and fruiting body parallels the divergent findings seen with lion's mane.

Chaga: Blood Sugar

Human cell studies and studies in mice suggest chaga glucans and other chaga polysaccharides may lower blood sugar levels [44][45]. Due to potential blood sugar-lowering effects, chaga should be used with caution in people with hypoglycemia, diabetes, or those taking anti-diabetes medications [45]. However, no human clinical trials have confirmed these blood sugar effects.

Chaga: Anti-Tumor Activity

Cell studies and animal models suggest chaga polysaccharides may slow the growth of certain types of cancerous cells and tumors [44]. These findings are exclusively preclinical and cannot be extrapolated to human use.

Summary: Evidence Quality

Claim	Lion's Mane Evidence	Chaga Evidence
Cognitive enhancement (healthy adults)	Multiple RCTs — negative	No human studies
Cognitive benefit (mild cognitive impairment)	1 small RCT — positive	No human studies
Alzheimer's disease	1 small RCT — negative	No human studies
Depression/anxiety	Small studies — mixed/weak	No human studies
Gut health	No human studies (lion's mane alone)	No human studies
Nerve injury/neuropathy	Animal studies only	No studies
Immune modulation	Lab and animal studies only	Lab and animal studies only
Blood sugar reduction	Not studied	Lab and animal studies only
Anti-tumor effects	Lab and animal studies only	Lab and animal studies only

Recommended Dosing

Lion's Mane

There is no established standard dose for lion's mane. Doses used in clinical trials have varied widely:

Study Population	Dose	Form	Duration	Outcome
Mild cognitive impairment [26]	960 mg x 3 daily (2,880 mg total)	Dried powdered fruiting body tablets	16 weeks	Positive
Mild Alzheimer's disease [29]	1,050 mg x 3 daily (3,150 mg total)	Erinacine A-enriched mycelium extract	49 weeks	Negative
Healthy older adults [20]	3,200 mg/day	Powdered fruiting body	12 weeks	Minimal benefit
Healthy young adults [21]	5,000 mg x 2 daily (10,000 mg total)	1:1 dried mushroom:extract	4 weeks	Negative
Healthy young adults [22]	1,000 mg (single dose)	Fruiting body	Acute	Negative
Healthy young adults [23]	3,000 mg (single dose)	Fruiting body extract	Acute	Negative
Healthy young adults [24]	1,800 mg/day	Not specified	28 days	Mixed
Depression (women) [31]	2,000 mg/day	Powdered fruiting body in cookies	4 weeks	Not significant
Anxiety/depression (overweight women) [32]	1,500 mg/day	1,200 mg mycelium + 300 mg fruiting body extract	8 weeks	Mixed

Typical supplemental doses range from 500 mg to 3,000 mg per day. Most positive findings (limited to mild cognitive impairment) used approximately 2,000–3,200 mg per day of dried fruiting body powder for at least 8–16 weeks [26][20].

Key considerations: Effects in the one positive cognitive study declined within 4 weeks of stopping supplementation, suggesting ongoing use may be necessary [26]. No dose-response relationship has been established. Whether fruiting body, mycelium, or a combination is optimal remains unknown. Long-term data beyond 49 weeks are limited [2][29].

Chaga

No human clinical trials exist to guide dosing. Traditional use as tea typically involves steeping dried chaga chunks in hot water. Supplement doses on the market range from 500 mg to 3,000 mg per day, but these are not evidence-based.

Critical warning: Due to chaga's extremely high oxalate content, doses above 3 grams per day carry a risk of kidney injury (see Safety section) [46][47][48].

Safety and Side Effects

Lion's Mane Safety

Lion's mane supplements have been safely used for up to one year in several clinical studies. The FDA classifies lion's mane as Generally Recognized as Safe (GRAS) when used as a food ingredient [49]. Toxicological studies in animals and limited human trials have shown no significant adverse effects at typical supplemental doses (up to 3 g/day) [2][50].

Reported side effects include abdominal discomfort and nausea, which appear to be uncommon and generally mild [26][29].

Allergic reactions (rare but documented): A 63-year-old man developed shortness of breath likely due to an allergic reaction approximately 4 months after starting a lion's mane extract supplement [51]. A 53-year-old man developed skin rash upon contact with lion's mane after cultivating the mushroom for one month [52]. People who are allergic to other mushrooms should avoid lion's mane [1].

Bleeding risk (theoretical): A test-tube study showed that lion's mane extract can modestly inhibit platelet aggregation, indicating it may increase the risk of bleeding. However, the antiplatelet effect was less than that of aspirin and even less than that of white button mushroom, indicating the risk is probably very low. Lion's mane did not affect prothrombin time or INR, indicating it does not have anticoagulant effects [53].

HMGCR immune-mediated necrotizing myopathy: Due to potential statin-like compounds in lion's mane, people with a history of HMGCR IMNM (an autoimmune condition most commonly triggered by statin medication) should avoid lion's mane mushrooms and other mushroom supplements, as they may cause a flare-up of the autoimmune reaction [1].

Interference with fungal infection testing: The 1,3-beta-D-glucan from mushrooms can potentially interfere with beta-glucan assays used to diagnose fungal infections. Inform your doctor if you are taking any mushroom supplement and are being tested for fungal infection [54].

Pregnancy and breastfeeding: There is insufficient safety data. Avoidance is recommended [2]. Individuals with autoimmune conditions should consult their physician before using lion's mane due to potential immune-stimulating effects [2].

Chaga Safety

Chaga presents more serious safety concerns than lion's mane, primarily related to its extremely high oxalate content.

Oxalate nephropathy — the major risk: Chaga naturally contains very high concentrations of oxalic acid [19]. Oxalic acid can bind to minerals (particularly calcium) to form oxalate crystals that accumulate in the kidneys and cause injury. Three case reports document this:

Case 1: A 72-year-old woman in Japan developed oxalate-induced kidney nephropathy (decreased kidney function due to calcium oxalate crystals deposited in kidney tubules) after consuming 4–5 teaspoons of chaga powder daily for six months [46].

Case 2: A 69-year-old man in Korea developed acute kidney injury after consuming 10–15 grams of chaga powder plus 500 mg of vitamin C for 3 months. He recovered one month after stopping supplementation and receiving treatment [47].

Case 3: A 49-year-old man in Korea suffered permanent kidney injury and was diagnosed with end-stage renal disease requiring ongoing hemodialysis due to chaga-induced oxalate nephropathy. He had consumed 3 grams of chaga powder daily for four years, then increased to 9 grams daily for one year. Testing of his chaga powder revealed an extremely high oxalate concentration of 140 mg per gram of powder [48].

Who should NOT take chaga: People with kidney disease, people with a history of calcium oxalate kidney stones, and people at risk of kidney problems.

Blood sugar effects: Due to potential blood sugar-lowering effects shown in preclinical studies, chaga should be used with caution in people with hypoglycemia, diabetes, or those taking anti-diabetes medications [45].

Bleeding risk: Chaga contains a protein that inhibits platelet aggregation, which could potentially increase the risk of bleeding. People who take blood-thinning medication should consult their physician before using chaga [55].

Immune stimulation: Preliminary research suggests chaga may have immune-stimulating effects. People with autoimmune conditions (e.g., rheumatoid arthritis, Hashimoto's thyroiditis, Graves' disease, multiple sclerosis, systemic lupus erythematosus) should consult their physician before using chaga [42].

Safety Comparison Table

Safety Concern	Lion's Mane	Chaga
Generally Recognized as Safe (GRAS)	Yes (as food ingredient)	No
Kidney damage risk	Not reported	High (oxalate nephropathy)
GI side effects	Mild, uncommon	Not well characterized
Allergic reactions	Rare but documented	Not well characterized
Bleeding risk	Theoretical (less than aspirin)	Theoretical
Immune stimulation concerns	Possible	Possible
Safe in pregnancy	Insufficient data	Insufficient data
Safe in kidney disease	Likely safe	Contraindicated
Longest safe use in studies	49 weeks	No human studies

Drug Interactions

Lion's Mane

Anticoagulants and antiplatelet drugs (warfarin, aspirin, clopidogrel, heparin): Lion's mane may have a mild antiplatelet effect, though less than aspirin. Use caution and consult a healthcare provider if combining [53].

Diabetes medications (insulin, metformin, sulfonylureas): While lion's mane has not shown blood sugar effects in human studies, preclinical evidence suggests potential hypoglycemic activity. Monitor blood glucose if using concurrently [1].

Immunosuppressants (cyclosporine, tacrolimus, corticosteroids): Lion's mane's potential immunomodulatory effects could theoretically interfere with immunosuppressive therapy. Consult a physician before combining [2].

Statin medications (atorvastatin, rosuvastatin, simvastatin): Due to potential statin-like compounds in lion's mane, people with HMGCR IMNM should avoid it. For others, no interaction has been documented, but awareness is warranted [1].

Beta-glucan assay interference: Lion's mane may cause false-positive results on the serum beta-D-glucan test used to diagnose invasive fungal infections. Inform your doctor of supplement use before testing [54].

Chaga

Anticoagulants and antiplatelet drugs (warfarin, aspirin, clopidogrel, heparin): Chaga contains a protein that inhibits platelet aggregation. Concurrent use may increase bleeding risk. Consult a physician before combining [55].

Diabetes medications (insulin, metformin, sulfonylureas): Preclinical studies suggest chaga may lower blood sugar. Combined use could increase the risk of hypoglycemia. Monitor blood glucose closely [45].

Immunosuppressants: Chaga's potential immune-stimulating effects could counteract immunosuppressive therapy. Consult a physician [42].

Drugs cleared by the kidneys: Given chaga's potential for oxalate-induced kidney injury, concurrent use with nephrotoxic drugs (NSAIDs, aminoglycosides, certain chemotherapy agents) may compound kidney damage risk [46][47][48].

Drug Interaction Summary Table

Drug Class	Lion's Mane Risk	Chaga Risk
Blood thinners (warfarin, aspirin)	Low (mild antiplatelet)	Moderate (platelet inhibition)
Diabetes medications	Theoretical	Theoretical (blood sugar lowering)
Immunosuppressants	Theoretical	Theoretical (immune stimulation)
Nephrotoxic drugs	Not applicable	Elevated risk
Beta-glucan diagnostic assay	Interference possible	Interference possible

Dietary Sources

Lion's Mane

Lion's mane is edible and has been consumed as food for centuries in East Asia, where it is prized for its seafood-like flavor often compared to crab or lobster meat [2][3].

Fresh lion's mane mushrooms are increasingly available at specialty grocery stores and farmers' markets, particularly in North America and Europe. They can be:

• Sauteed in butter or oil over medium-high heat for a crispy exterior and tender interior [2]
• Roasted at 375°F (190°C) for 15–20 minutes
• Added to soups by simmering sliced pieces with vegetables and broth for 20–30 minutes
• Stir-fried with garlic, onions, and soy sauce
• Dried for long-term storage, then rehydrated or ground into powder for teas and smoothies

It is recommended to cook lion's mane rather than consuming it raw, as the chitin in mushroom cell walls can cause digestive discomfort and cooking improves digestibility [2].

Growing your own: Lion's mane can be cultivated at home or commercially on hardwood substrates. Indoor cultivation using sterilized bags of hardwood sawdust supplemented with wheat bran can produce fruiting bodies in 2–5 weeks. Outdoor cultivation on inoculated hardwood logs requires 1–2 years for the first harvest but can yield mushrooms for up to 6 years from a single log [2].

Lion's mane coffee and beverages: Adding lion's mane powder to coffee has become a popular trend, but as noted above, the small amounts typically used (1–2 grams) provide negligible nutritional benefit [17].

Chaga

Chaga is not a typical food item due to its tough, charcoal-like texture. Traditional consumption methods include:

Chaga tea: The most traditional preparation. Dried chaga chunks are simmered in hot water for several hours to extract bioactive compounds. The resulting dark liquid has an earthy, slightly bitter flavor sometimes compared to coffee [14].

Chaga powder can be added to hot water, coffee, smoothies, or other beverages. Chaga tinctures are alcohol-based extracts that concentrate bioactive compounds.

Wild harvesting: Chaga grows naturally on birch trees in cold-climate regions. It appears as a dark, cracked, irregular growth on the trunk. Only chaga from birch trees is traditionally used — specimens from other trees may have different chemical compositions [14]. Wild-harvested chaga may carry higher contamination risks from heavy metals absorbed from polluted soils [2].

Sustainability concerns: Wild chaga harvesting is regulated in some regions. Sustainable practices and certifications (such as PEFC) exist for forest management, and uncontrolled wild collection has been deemed unsustainable for long-term supply [2].

What Supplements Cannot Replace

Neither lion's mane nor chaga provides meaningful amounts of the vitamins and minerals most commonly deficient in Western diets. Fresh lion's mane is a moderate source of biotin and riboflavin, but supplement forms (powders and extracts) are consumed in such small amounts (1–3 grams) that their nutritional contribution is negligible. Chaga has no documented nutritional value as a food beyond its polysaccharide content.

A well-formulated multivitamin addresses nutritional gaps far more effectively than mushroom supplements. For comprehensive micronutrient coverage, see a dedicated evidence-based multivitamin rather than relying on functional mushroom products.

References

1. ConsumerLab. "Lion's Mane and Chaga Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/lions-mane-and-chaga/lions-mane-chaga/

2. Grokipedia. "Lion's Mane Mushroom." https://grokipedia.com/page/Lions_mane_mushroom

3. He X, et al. "Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus." Int J Biol Macromol. 2017;97:228-237. doi:10.1016/j.ijbiomac.2017.01.040

4. Lai PL, et al. "Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus." Int J Med Mushrooms. 2013;15(6):539-554. doi:10.1615/IntJMedMushr.v15.i6.30

5. He X, et al. "Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion's Mane) mushroom." Int J Biol Macromol. 2017;97:228-237. doi:10.1016/j.ijbiomac.2017.01.040

6. Lazarev KF, et al. "Hericium erinaceus extracts promote neuronal differentiation and survival." Food Sci Technol. 2015.

7. Wong KH, et al. "Neuroregenerative potential of lion's mane mushroom, Hericium erinaceus." Food Sci Technol. 2015.

8. Kawagishi H, et al. "Erinacines A, B, and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum." Tetrahedron Lett. 1994;35(10):1569-1572.

9. Kawagishi H, et al. "Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus." Mycol Res. 1991.

10. Kawagishi H, et al. "Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum." Tetrahedron Lett. 1996;37(41):7399-7402.

11. Akramiene D, et al. "Effects of beta-glucans on the immune system." Medicina (Kaunas). 2007;43(8):597-606. PMID: 17895634

12. Doar JT, et al. "Differential inflammatory effects of lion's mane mycelium and fruiting body extracts on human blood cells." Immuno. 2026.

13. De Felice B, et al. "Chemical structure and biological activity of glucans from Hericium erinaceus." Int J Biol Macromol. 2020;162:921-928. doi:10.1016/j.ijbiomac.2020.06.199

14. Lee MW, et al. "Traditional uses and pharmacological studies of Inonotus obliquus." Mycobiology. 2008;36(4):195-202. doi:10.4489/MYCO.2008.36.4.195

15. McCleary BV, et al. "Measurement of beta-glucan in mushrooms and mycelial products." J AOAC Int. 2016;99(2):364-373. doi:10.5740/jaoacint.15-0289

16. Food Data Central. "Mushroom, lion's mane." U.S. Department of Agriculture. Accessed June 27, 2025. https://fdc.nal.usda.gov/

17. Kala M, et al. "Nutritional evaluation of lion's mane-enriched instant coffee." Pharmaceuticals (Basel). 2024.

18. Windsor JB, et al. "Analysis of commercially available chaga mycelium fermented grain supplements." Int J Mol Sci. 2025.

19. Glamoclija J, et al. "Chemical characterization and biological activity of chaga (Inonotus obliquus), a medicinal 'mushroom'." J Ethnopharmacol. 2015;162:323-332. doi:10.1016/j.jep.2014.12.069

20. Saitsu Y, et al. "Improvement of cognitive functions by oral intake of Hericium erinaceus." Biomed Res. 2019;40(4):125-131. doi:10.2220/biomedres.40.125

21. Grozier CD, et al. "Effects of short-term Hericium erinaceus supplementation on cognitive performance and metabolic flexibility." Int J Exerc Sci. 2022;15(2):1366-1377.

22. La Monica MB, et al. "Acute effects of naturally occurring guaiacol and hericium erinaceus on cognitive function, mood, and reaction time." Nutrients. 2023;15(20):4396. doi:10.3390/nu15204396

23. Surendran S, et al. "The acute effects of lion's mane mushroom (Hericium erinaceus) extract on cognitive function and mood." Front Nutr. 2025.

24. Docherty S, et al. "The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study." Nutrients. 2023.

25. Docherty S, et al. "The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults." Nutrients. 2023.

26. Mori K, et al. "Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial." Phytother Res. 2009;23(3):367-372. doi:10.1002/ptr.2634

27. Phungviwatnikul T, et al. "A review of the effects of mushrooms on mood and neurocognitive health across the lifespan." Neurosci Biobehav Rev. 2024.

28. Phungviwatnikul T, et al. "A review of the effects of mushrooms on mood and neurocognitive health." 2024.

29. Li IC, et al. "Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study." Front Aging Neurosci. 2020;12:155. doi:10.3389/fnagi.2020.00155

30. Chen YW, et al. "Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode unipolar depression." Neuropsychiatr Dis Treat. 2015;11:911-918. doi:10.2147/NDT.S81432

31. Nagano M, et al. "Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake." Biomed Res. 2010;31(4):231-237. PMID: 20834180

32. Vigna L, et al. "Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity." Evid Based Complement Alternat Med. 2019;2019:7861297. doi:10.1155/2019/7861297

33. Nagano M, et al. "Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake." Biomed Res. 2010;31(4):231-237.

34. Vigna L, et al. "Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity." Evid Based Complement Alternat Med. 2019.

35. Liu JH, et al. "Anti-Helicobacter pylori activity of bioactive components isolated from Hericium erinaceus." J Ethnopharmacol. 2016;183:54-58. doi:10.1016/j.jep.2016.02.039

36. Wang M, et al. "Gastroprotective effects of polysaccharide from Hericium erinaceus against ethanol-induced gastric mucosal lesion." Int J Med Mushrooms. 2015;17(11):1083-1089.

37. Therkelsen SP, et al. "Effect of a medicinal Agaricus blazei Murill-based mushroom extract, AndoSan, on symptoms, fatigue and quality of life in patients with ulcerative colitis." PLoS One. 2016;11(3):e0150191. doi:10.1371/journal.pone.0150191

38. Wong KH, et al. "Neuroregenerative potential of lion's mane mushroom, Hericium erinaceus." Food Sci Technol. 2015.

39. Yi Z, et al. "Protective effects of lion's mane mushroom against cisplatin-induced neuropathic pain." Evid Based Complement Alternat Med. 2015;2015:236749.

40. Ustun R, et al. "Analgesic effects of Hericium erinaceus polysaccharides in chemically-induced diabetic neuropathy." Int J Exp Clin Anat. 2019.

41. Various authors. "Erinacine S protects oligodendrocytes and promotes myelin sheath formation." In vitro and animal models.

42. Kim YR. "Immunomodulatory activity of the water extract from medicinal mushroom Inonotus obliquus." Mycobiology. 2005;33(3):158-162. doi:10.4489/MYCO.2005.33.3.158

43. Mishra SK, et al. "Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice." J Ethnopharmacol. 2012;143(2):524-532. doi:10.1016/j.jep.2012.07.008

44. Lu Y, et al. "Recent developments in Inonotus obliquus (Chaga mushroom) polysaccharides." Polymers (Basel). 2021;13(9):1441. doi:10.3390/polym13091441

45. Ying YM, et al. "Hypoglycaemic activity of lanosteryl triterpenes from Inonotus obliquus." Phytochemistry. 2014;108:171-178. doi:10.1016/j.phytochem.2014.09.022

46. Kikuchi Y, et al. "Oxalate nephropathy caused by daily intake of chaga mushroom." Clin Nephrol. 2014;81(6):440-444. doi:10.5414/CN107655

47. Ohyun K, et al. "Chaga mushroom-induced oxalate nephropathy." Medicine. 2022;101(40):e31042. doi:10.1097/MD.0000000000031042

48. Lee SH, et al. "Chaga mushroom-induced oxalate nephropathy causing end-stage renal disease." J Korean Med Sci. 2020;35(19):e122. doi:10.3346/jkms.2020.35.e122

49. U.S. Food and Drug Administration. "Generally Recognized as Safe (GRAS) — Hericium erinaceus."

50. Li IC, et al. "A toxicological assessment of Hericium erinaceus (Lion's mane)."

51. Nakatsugawa M, et al. "Respiratory distress caused by ingestion of Hericium erinaceum." Intern Med. 2003;42(7):632-634. PMID: 12879958

52. Maes M, et al. "Contact dermatitis from lion's mane cultivation." Contact Dermatitis. 1999;40(5):275-276.

53. Poniedzialek B, et al. "Evaluation of antiplatelet activity of lion's mane mushroom, Hericium erinaceus." Nutrients. 2019;11(12):2857. doi:10.3390/nu11122857

54. Vu-Ticar P, et al. "False-positive beta-D-glucan testing due to mushroom supplement use." Hospitalist. 2022.

55. Hyun KW, et al. "Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus." Peptides. 2006;27(6):1173-1178. doi:10.1016/j.peptides.2005.10.005